Erste Asset Management Gmb H Aerie Pharmaceuticals Inc Transaction History

Erste Asset Management Gmb H

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Nov 26, 2024	SELL	$4.95 - $9.16 $70,785 - $130,988	-14,300 Closed	0 $0
Q3 2019 Nov 22, 2024	SELL	$18.41 - $28.0 $263,263 - $400,400	-14,300 Closed	0 $0
Q1 2019 Nov 22, 2024	BUY	$36.32 - $49.25 $519,376 - $704,275	14,300 New	14,300 $648 Million
Q4 2018 Nov 26, 2024	BUY	$33.0 - $60.04 $471,900 - $858,572	14,300 New	14,300 $511 Million

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Erste Asset Management Gmb H with notifications on news.